In a secondary analysis of 612 patients with acute ischaemic stroke from the CATIS trial, higher plasma CD147 at admission was associated with higher odds of cognitive impairment at 3 months (OR 1.75, 95% CI 1.21–2.51) and slightly improved risk prediction.
Secondary analysisn = 612
Zhao et al. Plasma Cluster of Differentiation 147 and Cognitive Impairment After Acute Ischemic Stroke